Richard Scott Struthers, President & CEO: Crinetics Pharmaceuticals CRNX Sell · Filed 23/11/06

Trade details

Type: Insider sale
Amount: $6,083,945.92
Shares · price: 199,082 sh · $30.56 a share
Held after: 135,522 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Richard Scott StruthersPresident & CEO
Trade date: 23/11/03
Filed: 23/11/06
Days to filing: 3 days

Sold 59.5% of holdings

Share of holding sold: 59.5%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/10/04~23/12/03

Richard Scott Struthers's recent trades

Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$489.7K
13,196 sh
$489.7K
Filed 03/18
Traded 03/16
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$331.8K
8,785 sh
$331.8K
Filed 03/18
Traded 03/16
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$180K
4,000 sh
$180K
Filed 25/09/30
Traded 25/09/26
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$562.5K
16,463 sh
$562.5K
Filed 25/03/21
Traded 25/03/19
Richard Scott StruthersPresident & CEO
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$30.5K
875 sh
$30.5K
Filed 25/03/21
Traded 25/03/19

Richard Scott Struthers, CEO — sold $6.1M of Crinetics Pharmaceuticals CRNX · 59.5% of holdings · 10b5-1 plan | Whalegun